Additional file 4: of Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?

Wang, Meihua; Chen, Cong; Jemielita, Thomas; Anderson, James; Li, Xiaoyun; Hu, Chen; Kang, S.; Ibrahim, Nageatte; Ebbinghaus, Scot

doi:10.6084/m9.figshare.7698707.v1

40425_2019_513_MOESM4_ESM.docx (35.65 kB)

Additional file 4: of Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?

journal contribution

posted on 2019-02-08, 05:00 authored by Meihua Wang, Cong Chen, Thomas Jemielita, James Anderson, Xiaoyun (Nicole) Li, Chen Hu, S. Kang, Nageatte Ibrahim, Scot Ebbinghaus

Table S4. Effect and Predictive Value of “Tumor Size Changes” and “RECIST-based Response Status” on OS in Melanoma Patients (Ipilimumab-Refractory Melanoma (KEYNOTE -002)). (DOCX 35 kb)